陳俊仁，籍貫中國臺灣，研究員，博士生導(dǎo)師，中國醫(yī)學(xué)科學(xué)院北京協(xié)和醫(yī)學(xué)院特聘教授，中國醫(yī)學(xué)科學(xué)院血液病醫(yī)院信息與資源中心首席技術(shù)專家。2017年入選武漢市發(fā)改委“武漢‘光谷3551’人才計(jì)劃”；2018年入選中央組織部“國家人才創(chuàng)新長期項(xiàng)目”。獲得國家自然科學(xué)基金、國家重點(diǎn)研發(fā)計(jì)劃、院校創(chuàng)新工程項(xiàng)目、天津市科技計(jì)劃等項(xiàng)目資助。
     院校引進(jìn)人才，2020年加入院校，曾在中國種子集團(tuán)有限公司及中國中化集團(tuán)任中心常務(wù)副主任職務(wù)。

長期從事將數(shù)據(jù)科學(xué)應(yīng)用于血液系統(tǒng)疾病研究領(lǐng)域，從真實(shí)世界挖掘數(shù)據(jù)來回答臨床問題，現(xiàn)已開展的研究主要圍繞在血液系統(tǒng)疾病患者的全景醫(yī)學(xué)數(shù)據(jù)開展科學(xué)研究。從血液病的診斷、治療和預(yù)后等全維度，根據(jù)不同疾病亞型的發(fā)病特點(diǎn)和治療模式，結(jié)合數(shù)據(jù)科學(xué)技術(shù)，解決多學(xué)科領(lǐng)域交叉的共性難題，促進(jìn)數(shù)據(jù)科學(xué)與醫(yī)學(xué)研究領(lǐng)域知識體系的融通發(fā)展。2022年至今以通訊作者身份在“Nature Computational Science”、“Nature Communications”、“American Journal of Hematology”、“Leukemia”、“blood”等國際權(quán)威雜志發(fā)表論文15篇。

午夜92福利1000,午夜92福利1000,久久国产亚洲高清观看5388,美女不拍网站免费观看,欧美***天天久久综合精品,中文字幕日韩系列中文字幕,综合久久国产九一剧情麻豆,丰满人妻在线免费视频,奶子大逼又嫩操起来真爽

1．Junren Chen#*, Yigeng Cao#*, Yahui Feng#, Saibing Qi,# Donglin Yang#, Yu Hu#, Aiming Pang#, Qiujin Shen, Jieya Luo, Xiaowen Gong, Rongli Zhang, Xiaolin Zhai, Xueqian Li, Wen Yan, Xianjing Zhang, Mengyun Chen, Mingming Niu, Jialin Wei, Chen Liang, Weihua Zhai, Ningning Zhao, Xueou Liu, Sichang Liu, Wangsong Zhai, Ruixin Li, Xianfeng Shao, Dong Zhang, Mingyang Wang, Pan Pan, Mingyue Xu, Wei Zhang, Yunqiang Xu, Xiaofan Zhu, Ye Guo, Hong Wang, Zhen Song, Robert Peter Gale, Mingzhe Han, Sizhou Feng, Erlie Jiang*. Autonomous artificial intelligence prescribing a drug to prevent severe acute graft-versus-host disease in HLA-haploidentical transplants. Nat Commun 16(1):8391. (IF=15.7)

2．Fang Dong#*, Sen Zhang#, Caiying Zhu#, Zining Yang#, Lisha Wang#, Yao Ma, Jiayi Lu, Xialin Li, Xiaofang Wang, Nini Wang, Shanshan Zhang, Miner Xie, Jinhong Wang, Xiaobing Zhang, Yawei Zheng, Shihui Ma, Hideo Ema, Hui Cheng, Sha Hao, Toshio Suda, Yu Lan, Bing Liu, Ping Zhu*, Junren Chen*, Tao Cheng*. Heterogeneity of high-potency multilineage hematopoietic stem cells and identification of "Super" transplantability. Blood 146(5):546-557. (IF=21.1)

3．Xiaowen Gong#, Xiaolin Zhai,# Qiujin Shen#, Robert Peter Gale, Junren Chen*. Challenges determining the best target duration of deep molecular response after which to attempt achieving therapy-free remission in chronic myeloid leukaemia. Leukemia 39(4):810-815. (IF=13.4)

4．Yahui Feng#, Saibing Qi#, Yu Hu#, Wen Yan#, Yanping Ji, Mingyang Wang, Xiaowen Gong, Qiujin Shen, Wei Zhang, Huilan Liu, Xianjing Zhang, Mengyun Chen, Erling Chen, Xiaolin Zhai, Yi He, Donglin Yang, Aiming Pang, Mingzhe Han, Robert Peter Gale, Zimin Sun*, Erlie Jiang*, Junren Chen*. New criteria for estimating numbers of CD34-positive cells in a graft needed for posttransplant bone marrow recovery. Leukemia. 2024 Dec;38(12):2735-2738. (IF=12.8)

5．Qiujin Shen#, Xiaowen Gong#, Yahui Feng#, Yu Hu#, Tiantian Wang,Wen Yan, Wei Zhang, Saibing Qi, Robert Peter Gale, Junren Chen*. Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways? Blood Rev 68:101226. (IF=6.9)

6．Junren Chen#*, Robert Peter Gale, Yu Hu, Wen Yan, Tiantian Wang, Wei Zhang. Measurable residual disease (MRD)-testing in haematological and solid cancers. Leukemia 38(6):1202-1212. (IF=12.8)

7．Yahui Feng#, Saibing Qi#, Xueou Liu#, Li Zhang#, Yu Hu, Qiujin Shen, Xiaowen Gong, Wei Zhang, Junxia Wang, Wen Yan, Tiantian Wang, Huijun Wang, Zhen Song, Xiaofan Zhu*, Robert Peter Gale, Junren Chen*. Have we been qualifying measurable residual disease correctly? Leukemia 37(11):2168-2172. (IF=11.4)

8．Junren Chen#*, Robert Peter Gale, Yahui Feng, Yu Hu, Saibing Qi, Xueou Liu, Huaiping Zhu, Xiaowen Gong, Wei Zhang, Huilan Liu, Zimin Sun*. Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery? Leukemia 37(10):1963-1968. (IF=11.4)

9．Yigeng Cao#, Xiaowen Gong#, Yahui Feng#, Mingyang Wang#, Yu Hu#, Huilan Liu#, Xueou Liu#, Saibing Qi#, Yanping Ji#, Fang Liu#, Huaiping Zhu, Wenwen Guo, Qiujin Shen, Rongli Zhang, Ningning Zhao, Weihua Zhai, Xiaoqiang Song, Xin Chen, Liangquan Geng, Xia Chen, Xuetong Zheng, Qiaoling Ma, Baolin Tang, Jialin Wei, Yong Huang, Yuanyuan Ren, Kaidi Song, Donglin Yang, Aiming Pang, Wen Yao, Yi He, Yue Shang, Xiang Wan, Wei Zhang, Song Zhang, Guangyu Sun, Sizhou Feng, Xiaofan Zhu, Mingzhe Han, Zhen Song, Ye Guo*, Zimin Sun*, Erlie Jiang*, Junren Chen*. The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases. Am J Hematol. 2023 Feb;98(2):309-321. (IF=13.265)

10．Xueou Liu#, Yigeng Cao#, Ye Guo#, Xiaowen Gong#, Yahui Feng#, Yao Wang#, Mingyang Wang, Mengxuan Cui, Wenwen Guo, Luyang Zhang, Ningning Zhao, Xiaoqiang Song, Xuetong Zheng, Xia Chen, Qiujin Shen, Song Zhang, Zhen Song, Linfeng Li, Sizhou Feng, Mingzhe Han, Xiaofan Zhu*, Erlie Jiang*, Junren Chen*. Dynamic forecasting of severe acute graft-versus-host disease after transplantation. Nat Comput Sci 2(3):153-159. (IF=11.3)